| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 326.19B | 301.10B | 287.88B | 272.58B | 255.05B |
| Gross Profit | 89.40B | 81.59B | 68.99B | 62.98B | 61.12B |
| EBITDA | 43.58B | 35.98B | 27.67B | 22.38B | 23.08B |
| Net Income | 23.63B | 18.49B | 11.21B | 7.13B | 6.73B |
Balance Sheet | |||||
| Total Assets | 373.67B | 341.35B | 334.79B | 307.39B | 290.90B |
| Cash, Cash Equivalents and Short-Term Investments | 31.83B | 30.68B | 18.98B | 14.92B | 14.07B |
| Total Debt | 44.40B | 46.31B | 56.50B | 51.94B | 49.70B |
| Total Liabilities | 195.13B | 199.13B | 205.30B | 196.51B | 185.47B |
| Stockholders Equity | 174.89B | 138.78B | 126.41B | 107.90B | 101.97B |
Cash Flow | |||||
| Free Cash Flow | 2.26B | 24.91B | -375.00M | 1.35B | 2.48B |
| Operating Cash Flow | 17.50B | 35.45B | 8.97B | 13.74B | 11.39B |
| Investing Cash Flow | -17.13B | -9.06B | -7.55B | -10.51B | -7.50B |
| Financing Cash Flow | -7.79B | -14.54B | 749.00M | -2.69B | -4.27B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥422.39B | 18.53 | 14.28% | 2.40% | 8.33% | 27.80% | |
74 Outperform | ¥589.55B | 34.11 | 5.25% | 2.13% | -7.11% | 68.57% | |
72 Outperform | ¥495.23B | 36.32 | ― | 2.50% | 1.45% | 0.37% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | ¥364.73B | 27.24 | ― | 1.65% | 5.02% | 19.84% | |
56 Neutral | ¥834.33B | -12.70 | 1.88% | 6.16% | 1.98% | -48.28% | |
55 Neutral | ¥660.36B | 432.51 | 5.94% | 0.56% | 7.03% | -53.53% |